INS and Alzheimer disease: Changes to insulin signaling, particularly desensitization to insulin, result in chronic inflammation and are a known risk factor for AD across human and rodent in vitro and in vivo models (Baker et al., 2011; Blázquez et al., 2014; Craft et al., 2017).